Publications
Publications
- March 2024 (Revised March 2024)
- HBS Case Collection
Miracle Therapeutics (B)
By: Satish Tadikonda, William Marks and Wendi Yajnik
Abstract
Supplements the (A) case. Following on the negotiations detailed in the Miracle Therapeutics (A) case, Beth Sharp and Jennifer Brilliant from Miracle Therapeutics face new challenges with their company's funding and intellectual property (IP) after several missteps. The company and its young CEO are at a crossroads and must solve the challenges faced by many early-stage life science companies. The case follows how they navigate these issues to set Miracle on the right course.
Keywords
Business Startups; Financing and Loans; Intellectual Property; Problems and Challenges; Business or Company Management
Citation
Tadikonda, Satish, William Marks, and Wendi Yajnik. "Miracle Therapeutics (B)." Harvard Business School Supplement 824-044, March 2024. (Revised March 2024.)